-+ 0.00%
-+ 0.00%
-+ 0.00%

Kala Bio delays Q2 Form 10-Q filing, cites added time for liquidity disclosure

PUBT·08/14/2026 14:14:43
Listen to the news
Kala Bio delays Q2 Form 10-Q filing, cites added time for liquidity disclosure
  • Kala Bio filed a Form 12b-25 to delay its quarterly report for the period ended June 30, 2026.
  • The company needs more time to complete liquidity and capital resources analysis and related disclosures.
  • Management expects to file the Form 10-Q by the fifth calendar day after the original due date.
  • The notice flagged no anticipated significant change in results of operations versus the prior-year period.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kala Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-26-008832), on August 14, 2026, and is solely responsible for the information contained therein.